AEON icon

AEON Biopharma

81 hedge funds and large institutions have $222M invested in AEON Biopharma in 2022 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 18 increasing their positions, 3 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
81
Holders Change
+8
Holders Change %
+10.96%
% of All Funds
1.4%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
13
Increased
18
Reduced
3
Closed
5
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
PCM
76
Pinz Capital Management
New York
$140K
BlackRock
77
BlackRock
New York
$99K +$99K +139 New
6CM
78
683 Capital Management
New York
$98K
UBS Group
79
UBS Group
Switzerland
$32K +$21.1K +29 +193%
EC
80
Elequin Capital
New York
$7K +$7K +10 New
Bank of Montreal
81
Bank of Montreal
Ontario, Canada
$6.26K +$719 +1,014 +13%
PMAM
82
Picton Mahoney Asset Management
Ontario, Canada
-$3.43M -4,861 Closed
KCM
83
Kawa Capital Management
Florida
-$686K -972 Closed
TCM
84
Tegean Capital Management
New York
-$491K -694 Closed
Citigroup
85
Citigroup
New York
-$245K -347 Closed
OCAM
86
Owl Creek Asset Management
New York
-$245K -347 Closed